These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 33604811)
1. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma. Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811 [TBL] [Abstract][Full Text] [Related]
2. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness. Golyan FF; Abbaszadegan MR; Forghanifard MM J Cell Biochem; 2019 Sep; 120(9):14838-14846. PubMed ID: 31016793 [TBL] [Abstract][Full Text] [Related]
3. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma. Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427 [TBL] [Abstract][Full Text] [Related]
4. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma. Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748 [TBL] [Abstract][Full Text] [Related]
6. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells. Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM Gene Expr Patterns; 2020 Sep; 37():119127. PubMed ID: 32711119 [TBL] [Abstract][Full Text] [Related]
7. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC. Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540 [TBL] [Abstract][Full Text] [Related]
8. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143 [TBL] [Abstract][Full Text] [Related]
9. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis. Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371 [TBL] [Abstract][Full Text] [Related]
10. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. Fardi Golyan F; Forghanifard MM Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953 [TBL] [Abstract][Full Text] [Related]
11. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma. Khales SA; Mozaffari-Jovin S; Geerts D; Abbaszadegan MR BMC Cancer; 2022 Dec; 22(1):1272. PubMed ID: 36474162 [TBL] [Abstract][Full Text] [Related]
12. TWIST1 Plays Role in Expression of Stemness State Markers in ESCC. Izadpanah MH; Forghanifard MM Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553636 [TBL] [Abstract][Full Text] [Related]
13. TWIST1 upregulates the MAGEA4 oncogene. Forghanifard MM; Rad A; Farshchian M; Khaleghizadeh M; Gholamin M; Moghbeli M; Abbaszadegan MR Mol Carcinog; 2017 Mar; 56(3):877-885. PubMed ID: 27533647 [TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30. Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035 [TBL] [Abstract][Full Text] [Related]
15. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling. Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849 [TBL] [Abstract][Full Text] [Related]
16. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
17. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma. Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma. Zhu B; Wang Y; Wang X; Wu S; Zhou L; Gong X; Song W; Wang D Diagn Pathol; 2018 Jul; 13(1):45. PubMed ID: 30021598 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44. Zuo J; Zhu K; Wang Y; Yu Z Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]